Juvenescence is a bio-pharma development company developing therapies focused on allowing people worldwide to live longer, healthier lives. Juvenescence involved in building an ecosystem of seasoned drug developers to support scientists, universities, and institutions specializing in aging, senescence, and the diseases of aging.
|Employees (est.) (Jul 2019)||20|
Juvenescence total Funding
Juvenescence latest funding size
Time since last funding
|a year ago|
|Foresite Capital, Jim Mellon, Apeiron Investment Group, Grok Ventures, Karim Hakimzadeh, Gregory Bailey, Andrew Banks, IPGL|
When was Juvenescence founded?
Juvenescence was founded in 2017.
Who are Juvenescence key executives?
Juvenescence's key executives are Gregory Bailey, David Ellam and Colin Watts.
How many employees does Juvenescence have?
Juvenescence has 20 employees.
Who are Juvenescence competitors?
Competitors of Juvenescence include GP Bullhound, Omega Healthcare Investors and Rock Health.
Where is Juvenescence headquarters?
Juvenescence headquarters is located at Virgin, UT, USA, Virgin.
Where are Juvenescence offices?
Juvenescence has an office in Virgin.
How many offices does Juvenescence have?
Juvenescence has 1 office.
Receive alerts for 300+ data fields across thousands of companies